News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]

Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]

Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) [Yahoo! Finance]

Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]

Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.

11/6/2024

04:05 pm

EOLS

-15.0%

MISS

7/31/2024

04:05 pm

EOLS

10.6%

MISS

5/7/2024

04:05 pm

EOLS

-1.2%

MISS

3/7/2024

04:05 pm

EOLS

-6.2%

MISS

Form SCHEDULE 13G/A Evolus, Inc. Filed by: Nantahala Capital Management, LLC

Form SC 13G/A Evolus, Inc. Filed by: PERCEPTIVE ADVISORS LLC

Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

Form SC 13G/A Evolus, Inc. Filed by: Stonepine Capital Management, LLC

Form S-8 Evolus, Inc.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}